Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing

Developing advanced therapies requires navigating critical decisions that directly impact a therapy’s long-term viability and manufacturability, potentially preventing a promising treatment from reaching patients. Focusing on two key decision points, this webinar demonstrates how early choices regarding cell banking and scale-up strategies can significantly affect development timelines, costs, and risks associated with Good Manufacturing Practice (GMP) manufacturing.

Learn how to avoid the largest risk areas and cost drivers in GMP cell bank development with practical, experience-driven insights. Case studies illustrate how to select and leverage the right-fit banking strategies to maintain focus on your program goals. Additionally, the discussion offers effective lot-size modeling and scale-up strategies to help your mesenchymal stem cell (MSC) and exosome manufacturing programs meet the increasing quantity demands of later phase clinical trials and commercialization.

Click below to view the on-demand webinar and gain a clearer path toward commercial success for your advanced therapy.